Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeFUNDINGTempo Raises $220M in New Capital to Enhance AI & 3D Sensor...

Tempo Raises $220M in New Capital to Enhance AI & 3D Sensor Technology

April 13, 2021

Tempo the first home fitness system that uses advanced 3D sensors and AI to analyze users’ motion to provide a personal training experience—today announced $220 million in new funding.

Tempo notes the Series C round was led by SoftBank Vision Fund 2* with participation from new investor Steadfast Capital Ventures, and returning investors DCM, General Catalyst, Norwest Venture Partners, and Bling Capital. This brings Tempo’s funding to date to nearly $300 million.

Tempo will allocate the new funding toward the continued enhancement of its AI and 3D sensor technology to further expand its cutting-edge, real-time form feedback and personal guidance for users. The company also recently announced vast expansions across its hardware, software, and content offerings to best supplement the training experience and continue to deliver a full, at-home gym and personal trainer experience.

“Tempo was launched on the premise that the most advanced and versatile technology can unlock human potential by redefining the personal training experience. Today, our AI uses 3D sensors and is trained on over 5M workouts over 40K hours to give our users the most effective and personalized workouts possible,” said Moawia Eldeeb, Co-Founder and CEO of Tempo. “This new funding allows Tempo to further develop its AI to expand our class categories and content offerings.”

With its unique offering for at-home fitness, Tempo has gained significant momentum since launching in 2020. In the past year alone, Tempo saw its sales increase by 10 times and has seen 0% subscription cancellation.

“The fitness landscape has transformed dramatically as more consumers seek home fitness solutions. By providing personalized AI generated feedback through its computer vision technology, Tempo delivers the experience of working out with a personal trainer to consumers in their homes,” said Jeff Housenbold, Managing Partner, SoftBank Investment Advisers. “We’re excited to partner with Moawia and the Tempo team to support their ambition to help people progress in their fitness journeys at home.”

As the only complete yet incomparably compact and connected home training solution on the market, the Tempo Studio combines the hands-on guidance of a personal trainer, the motivation of a group fitness class, and premium design-forward equipment. After more than six years of developing Tempo’s flagship product, the company remains dedicated to providing the most efficient and personalized fitness experience to its community.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy